Friends in High Places
This collection features companies that strategically invest in political lobbying to influence policy and secure their competitive edge. Our analysts have carefully selected firms that leverage government relationships to create regulatory advantages and sustained profitability.
Your Basket's Financial Footprint
Concise summary and investor takeaways for the provided basket market capitalisation data.
- Large-cap dominance generally implies lower volatility, more stable returns, and closer tracking of broad market movements.
- Treat as a core holding for portfolio stability rather than a speculative, high-growth trade.
- Expect steady, long-term appreciation rather than explosive short-term gains; growth is likely moderate.
LMT: $113.27B
BA: $164.28B
XOM: $480.51B
- Other
About This Group of Stocks
Our Expert Thinking
These companies aren't just spending on lobbying—they're making strategic investments to shape regulations in their favor. By creating favorable regulatory environments and securing subsidies, these firms build powerful competitive moats that can lead to consistent long-term profitability.
What You Need to Know
This collection includes established companies in heavily regulated sectors like defense, energy, finance, and pharmaceuticals. Their significant political spending indicates a deliberate strategy of using government relationships as a business advantage, potentially offering resilience against regulatory changes.
Why These Stocks
We've identified companies that consistently rank as top spenders on lobbying and political contributions. These selections are based on public data showing both the scale and consistency of their investment in political influence, highlighting a clear strategic focus.
Why You'll Want to Watch These Stocks
Election Boost Coming
Major election cycles typically trigger increased corporate political spending as companies position themselves with potential new lawmakers. This could be a catalyst for many stocks in this collection.
Regulatory Moat Advantage
These companies aren't just playing defense against regulations—they're actively shaping the rules of their industries. This creates lasting competitive advantages that more passive competitors simply can't match.
Connected in All the Right Places
From defense contracts to energy policy and healthcare reforms, these companies have established strategic relationships with policymakers that can help them navigate changing political landscapes.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Drug Pricing Power | Major Pharma Stocks 2025
Following plans by major drugmakers to raise prices on hundreds of medications, the pharmaceutical industry is showcasing its significant pricing power. This development highlights an investment opportunity centered on established pharmaceutical companies capable of translating market dominance into revenue growth.
Automation & Software Investment Theme Overview
Recent labor data reveals a split market, with low private-sector jobless claims contrasting with high unemployment driven by federal layoffs. This dynamic creates an investment opportunity in companies providing automation, software, and efficiency-boosting services as businesses prioritize productivity over expanding their payrolls.
Oyo's IPO Plans: Hospitality Sector Recovery Explained
Global hospitality firm Oyo's parent company has revived its IPO plans, signaling renewed confidence in the travel market. This high-profile listing could ignite investor interest across the entire hospitality and travel technology sector, creating opportunities for related service providers.